Milam Midazolam Lorlatinib
ModerateConcurrent administration of Lorbrexen in patients resulted in decreased oral midazolam AUC when midazolam was administered alone, suggesting that Lorbrexen is an inducer of CYP3A4/5.
These medicines are often taken together with some care. Your doctor may change a dose, space them apart or check on you more often. Make sure your doctor and pharmacist know you take both.